INVO Fertility, Inc (NASDAQ:IVF) Sees Large Growth in Short Interest

INVO Fertility, Inc (NASDAQ:IVF) saw a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 354,428 shares, a growth of 762.2% from the January 15th total of 41,109 shares. Based on an average trading volume of 40,305,247 shares, the days-to-cover ratio is currently 0.0 days. Currently, 15.0% of the company’s shares are sold short. Currently, 15.0% of the company’s shares are sold short. Based on an average trading volume of 40,305,247 shares, the days-to-cover ratio is currently 0.0 days.

Analysts Set New Price Targets

Separately, Maxim Group set a $4.00 price objective on shares of INVO Fertility in a research report on Tuesday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell” and an average target price of $4.00.

Institutional Trading of INVO Fertility

An institutional investor recently bought a new position in INVO Fertility stock. Citadel Advisors LLC purchased a new stake in shares of INVO Fertility, Inc (NASDAQ:IVF) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned 1.19% of INVO Fertility at the end of the most recent reporting period. 12.02% of the stock is currently owned by hedge funds and other institutional investors.

INVO Fertility Price Performance

IVF stock traded up $0.01 during midday trading on Tuesday, hitting $1.11. The stock had a trading volume of 594,178 shares, compared to its average volume of 20,746,982. The firm has a market cap of $2.65 million, a price-to-earnings ratio of 0.00 and a beta of 2.65. The business has a 50-day moving average of $1.16 and a two-hundred day moving average of $5.19. INVO Fertility has a 52-week low of $0.71 and a 52-week high of $123.52.

INVO Fertility Company Profile

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.